Amoxicillin; Omeprazole Magnesium; Rifabutin Patent Expiration
Amoxicillin; Omeprazole Magnesium; Rifabutin is Used for treating Helicobacter pylori infection in adults. It was first introduced by Redhill Biopharma Ltd
Amoxicillin; Omeprazole Magnesium; Rifabutin Patents
Given below is the list of patents protecting Amoxicillin; Omeprazole Magnesium; Rifabutin, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Talicia | US11878011 | Method for eradicating Helicobacter pylori infection in patients regardless of body mass index | May 27, 2042 | Redhill |
| Talicia | US10238606 | Pharmaceutical compositions for the treatment of Helicobacter pylori | Feb 12, 2034 | Redhill |
| Talicia | US11135172 | Rifabutin-based compositions and methods for treating Helicobacter pylori infection | Feb 12, 2034 | Redhill |
| Talicia | US11931463 | All-in-one fixed-dose combination for treating Helicobacter pylori infection | Feb 12, 2034 | Redhill |
| Talicia | US9050263 | Pharmaceutical compositions for the treatment of Helicobacter pylori | Feb 12, 2034 | Redhill |
| Talicia | US9498445 | Pharmaceutical compositions for the treatment of Helicobacter pylori | Feb 12, 2034 | Redhill |
| Talicia | US9603806 | Pharmaceutical compositions for the treatment of Helicobacter pylori | Feb 12, 2034 | Redhill |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Amoxicillin; Omeprazole Magnesium; Rifabutin's patents.
Latest Legal Activities on Amoxicillin; Omeprazole Magnesium; Rifabutin's Patents
Given below is the list recent legal activities going on the following patents of Amoxicillin; Omeprazole Magnesium; Rifabutin.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Yr, Small Entity | 08 May, 2024 | US9498445 |
| Recordation of Patent eGrant | 19 Mar, 2024 | US11931463 |
| Recordation of Patent Grant Mailed Critical | 19 Mar, 2024 | US11931463 |
| Email Notification Critical | 19 Mar, 2024 | US11931463 |
| Mail Patent eGrant Notification | 19 Mar, 2024 | US11931463 |
| Patent eGrant Notification | 19 Mar, 2024 | US11931463 |
| Patent Issue Date Used in PTA Calculation Critical | 19 Mar, 2024 | US11931463 |
| Email Notification Critical | 29 Feb, 2024 | US11931463 |
| Issue Notification Mailed Critical | 28 Feb, 2024 | US11931463 |
| Application Is Considered Ready for Issue Critical | 09 Feb, 2024 | US11931463 |
Amoxicillin; Omeprazole Magnesium; Rifabutin's Family Patents
